COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
HKSTP Crowns EPIC 2025 Winner: Champion of HKSTP EPIC 2025 NEU Battery Materials from Singapore Triumphs at Hong Kong’s Flagship I&T Mega Event
Hong Kong Science and Technology Parks Corporation (HKSTP) successfully concluded EPIC 2025, crowning NEU Battery Materials as Overall Champion. Record investment of US $105M, 1,200+ applications, and global diversity marked the event -
-
-
COMMUNIQUÉ DE PRESSE
BGSF, Inc. Reports Third Quarter 2025 Financial Results and Announced a Stock Buyback Plan
BGSF, Inc. reported Q3 2025 financial results with $26.9M in revenues and a stock buyback plan. Adjusted EPS increased to $0.08. Interim CEOs discuss strategic initiatives and growth prospects -
-
COMMUNIQUÉ DE PRESSE
5E Advanced Materials Welcomes U.S. Designation of Boron as a Critical Mineral, Strengthening Fort Cady Project
5E Advanced Materials secures U.S. Critical Minerals List inclusion for boron, reinforcing domestic supply chain and national security. Company set to be key boron supplier in high-demand markets -
COMMUNIQUÉ DE PRESSE
Communiqué de presse : ACAAI : L’étude pivot Dupixent menée par Sanofi et Regeneron a atteint l’ensemble de ses critères d’évaluation principaux et secondaires, réduisant les signes et symptômes de la rhinosinusite fongique allergique..
L'étude pivot Dupixent menée par Sanofi et Regeneron a atteint ses critères principaux et secondaires pour la rhinosinusite fongique allergique, avec une demande d'examen prioritaire par la FDA. Les résultats sont présentés au congrès annuel 2025 de l'ACAAI -
COMMUNIQUÉ DE PRESSE
Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review
Sanofi and Regeneron announce positive results from Dupixent pivotal study in allergic fungal rhinosinusitis, with sBLA accepted for FDA priority review
